Waters Corp (WAT) 114.54 $WAT
Global Glycobiology/Glycomics Market 2014-2019: Enzymes, Instruments, Kits, and Reagents
M2 - Mon Dec 08, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sj4p7d/glycobiologyglyco) has announced the addition of the "Glycobiology/Glycomics Market by Product, Application & by End User - Global Forecast to 2019" report to their offering. The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market. This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Glycomics Market, By Product 8 Glycomics Market, By Application 9 Glycomics Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bruker Corporation - Danaher Corporation - New England Biolabs - Prozyme - Shimadzu Corporation - Sigma-Aldrich Corporation - Takara Bio - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/sj...ologyglyco
A: 41.13 (-0.24), SIAL: 137.16 (-0.01), DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Metabolomics: Technologies and Applications - A Global Market Overview
M2 - Fri Nov 28, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/rkdkz4/metabolomics) has announced the addition of the "Metabolomics: Technologies and Applications - A Global Market Overview" report to their offering. The global markets for the above mentioned metabolomic analytical techniques, end-use applications and the therapeutic areas are analyzed in terms of value in USD. Metabolomic separation techniques account for over half of the global metabolomics market estimated at US$395.2 million in 2014 while detection techniques shares with US$308.8 million. Biomarker discovery projected to be the fastest growing end use sector with 2014-2020 CAGR of 25.2% and also estimated the largest market for metabolomics in 2014 with US$252.8 million closely followed by drug discovery with US$211.1 million. The report reviews, analyses and projects the metabolomics technologies, applications and therapeutic areas market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 9 independent countries across North America - The United States and Canada; Europe - France, Germany, Italy and the United Kingdom; Asia-Pacific - China, India and Japan. This global market report includes 306 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 20 key global players and 33 major players across North America - 20; Europe - 9; and Asia-Pacific - 4. The research also provides the listing of the companies engaged in research and development, manufacturing and supply of metabolomics technologies and instruments. The global list of companies covers addresses, contact numbers and the website addresses of 92 companies. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. APPLICATION ANALYSIS OF METABOLOMICS 3. KEY MARKET TRENDS 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC PART
ANNEXURE Companies Mentioned - Agilent Technologies - BASF SE - Biocrates Life Sciences AG - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - Genedata AG - GERSTEL GmbH & Co. KG - Human Metabolome Technologies, Inc. - LECO Corporation - Metabolomic Discoveries GmbH - Metabolomic Technologies Inc. - Metabolomx - Metabolon, Inc. - Phenomenome Discoveries Inc. - Shimadzu Corporation - Sigma-Aldrich Co. LLC. - Stemina Biomarker Discovery, Inc. - Thermo Fisher Scientific Inc - Waters Corporation For more information visit http://www.researchandmarkets.com/research/rk...tabolomics
A: 41.13 (-0.24), DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters
PR Newswire - Wed Nov 26, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Sequenom Inc. (NASDAQ: SQNM), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), Affymetrix Inc. (NASDAQ: AFFX), and Waters Corporation (NYSE: WAT). Free research on these five companies can be accessed at:http://investor-edge.com/register. The US markets on Tuesday, November 25, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,814.94, down 0.02% and the NASDAQ Composite closed at 4,758.25, up 0.07%. The S&P 500 finished the session 0.12% lower at 2,067.03. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 793.40, up 0.07%, with the index advancing 8.30% in the previous three months. Register for your complimentary reports on these five stocks at:
SQNM: 3.59 (-0.01), ILMN: 186.22 (+2.72), PKI: 43.99 (-0.06), WAT: 114.54 (+0.21), AFFX: 9.80 (+0.05)
Metabolomics Market - By Indication (Oncology, Cardiology) worth $2,100 Million by 2019 - Prominent Players in this Market - Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.) & Waters Corporation (U.S.)
M2 - Mon Nov 24, 3:44AM CST
According to a new market research report The "Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Waters Corporation to Gain from Strength in Pharmaceuticals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:40PM CST
On Nov 20, 2014, we issued an updated research report on Waters Corporation (WAT).
BLT: 17.52 (+0.17), WAT: 114.54 (+0.21)
12.1% Return Seen to Date on SmarTrend Waters Call (WAT)
Comtex SmarTrend(R) - Fri Nov 21, 9:38AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 1 month, Waters has returned 12.06% as of today's recent price of $116.42.
WAT: 114.54 (+0.21)
Watch for Waters to Potentially Pullback After Gaining 1.38% Yesterday
Comtex SmarTrend(R) - Thu Nov 20, 4:27PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $114.13 to a high of $116.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $114.58 on volume of 962,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 114.54 (+0.21)
Waters Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Nov 20, 4:27PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $114.13 to a high of $116.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $114.58 on volume of 962,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 114.54 (+0.21)
Global Chiral Chromatography Column Market Outlook, 2018 - Key Analysis of the $87 Million Industry
M2 - Tue Nov 18, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vtffgd/chiral) has announced the addition of the "Chiral Chromatography Column Market by type, Material, & by Application - Forecast to 2018" report to their offering. The chiral chromatography columns market size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2% Chiral Chromatography has evolved over the years and has become a method of choice for analysis, identification, and purification of a wide variety of compounds. The market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures in lesser amounts of time and provide more detailed results. This report categorizes the market into two broad segments, based upon type of columns, into empty columns and pre-packed columns. Thepre-packed columns market comprises of analytical and preparative columns. The analytical columns accounts for 62% of the overall market. The chiral chromatography columns market, by applications, is segmented into Liquid Chromatography (LC), Gas Chromatography (GC), Thin-layer chromatography (TLC),and Supercritical Fluid Chromatography (SFC). The LC market is further classified into High Performance Liquid Chromatography (HPLC), Ultra-High Performance Liquid Chromatography (UHPLC), Ultra-Fast Liquid Chromatography (UFLC) and Flash Chromatography. The Liquid chromatography (LC) subsegment holds the largest share 69% of the overall market in 2013. This high share of LC systems is attributed to the large-scale application of HPLC systems and the rising use of UHPLC systems. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Chiral Chromatography Columns Market, By Type 7 Chiral Chromatography Market, By Material 8 Chiral Chromatography Market, By Application 9 Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies - Daicel Corporation - Phenomenex, Inc. - Shimadzu Corporation - Sigma Aldrich Corporation - Thermo Fisher Scientific, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/vtffgd/chiral
A: 41.13 (-0.24), WAT: 114.54 (+0.21)
Waters Corporation Presentation at the Stifel 2014 Healthcare Conference to Be Webcast Live
Business Wire - Tue Nov 11, 12:10PM CST
Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will speak to the investment community at the Stifel 2014 Healthcare Conference at the New York Palace Hotel in New York, on Tuesday, November 18, 2014, at 8:00 a.m. Eastern Time.
WAT: 114.54 (+0.21)
Waters PATROL UPLC Process Analysis System Receives Product Innovation Leadership Award from Frost & Sullivan
Business Wire - Tue Nov 11, 8:05AM CST
Waters Corporation (WAT:NYSE) today announced it received the 2014 Product Innovation Award for PATROL UPLC(R) Process Analysis System from Frost & Sullivan in the Global Process Liquid Chromatography market.
WAT: 114.54 (+0.21)
Waters Earnings Review: 20 Days after Announcement Shares Up 3.6% (WAT)
Comtex SmarTrend(R) - Mon Nov 10, 10:53AM CST
When Waters (NYSE:WAT) reported earnings two weeks ago on October 21st, 2014, analysts, on average, expected the company to report earnings of $1.28 on sales of $486.7 million. The company actually reported EPS of $1.38 on sales of $493.2 million, beating EPS estimates by $0.09 and beating revenue estimates by $6.5 million. Shares of Waters have climbed from $107.17 to $111.05, representing a gain of 3.6% since the company reported earnings 20 days ago.
WAT: 114.54 (+0.21)
Waters Centers of Innovation Program Honors Colorado State University Laboratory
Business Wire - Tue Oct 28, 9:18AM CDT
At a ceremony at Colorado State University's Fort Collins, CO campus, Waters Corporation officially welcomed the University's Proteomics and Metabolomics Facility into its Centers of Innovation Program. Under the direction of Dr. Jessica Prenni, the facility has earned a reputation for excellence in applying non-targeted proteomics and metabolomics using liquid chromatography and mass spectrometry (LC/MS) to advance food and veterinary science and clinical and microbacterial research.
WAT: 114.54 (+0.21)
Position Paper Release, Acquisition Agreement, Quarterly Earnings, Technical Updates, and New Medicare Plans - Research Reports on Intercontinental, Marsh & McLennan, Waters, Teva and WellPoint
PR Newswire - Mon Oct 27, 7:50AM CDT
Today, Analysts Review released its research reports regarding Intercontinental Exchange, Inc. (NYSE: ICE), Marsh & McLennan Companies, Inc. (NYSE: MMC), Waters Corporation (NYSE: WAT), Teva Pharmaceutical Industries Limited (NYSE: TEVA) and WellPoint Inc. (NYSE: WLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7440-100free.
ICE: 221.73 (-1.70), TEVA: 57.09 (+0.33), WLP: 128.71 (+0.94), WAT: 114.54 (+0.21), MMC: 58.32 (-0.07)
Waters (WAT) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 22, 11:08AM CDT
The following Waters (WAT) conference call took place on October 21, 2014, 08:30 AM ET. This is a transcript of that earnings call:
WAT: 114.54 (+0.21)
Waters Corporation Selects Lecorpio's IP Management Solution to Unify Patent Process and Drive Better Business Decisions
PR Newswire - Wed Oct 22, 10:03AM CDT
Lecorpio, the leader in cloud-based Intellectual Property (IP) management and analytics, today announced that Waters Corporation has selected Lecorpio's intellectual asset management solution to unify its IP program and provide analytics to drive better business decisions.
WAT: 114.54 (+0.21)
NYSE stocks posting largest percentage increases
AP - Tue Oct 21, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
HLF: 37.98 (+0.20), POST: 42.51 (+0.49), W: 20.44 (-0.35), LRE: 7.00 (-0.20), LII: 95.68 (-0.36), ESI: 10.18 (-0.01), TRN: 28.45 (+0.07), PER: 6.38 (-0.16), VSLR: 8.97 (+0.18), WAT: 114.54 (+0.21), CNL: 55.15 (+0.20), SB: 3.86 (-0.17), PKG: 78.90 (-0.11)
Why Waters (WAT) Stock Is Up Today
at The Street - Tue Oct 21, 11:45AM CDT
Waters (WAT) is gaining Tuesday after beating analysts' estimates for earnings and revenue in the third quarter.
WAT: 114.54 (+0.21)
Waters (WAT) Marked As A Barbarian At The Gate
at The Street - Tue Oct 21, 11:41AM CDT
Trade-Ideas LLC identified Waters (WAT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
WAT: 114.54 (+0.21)
Global Glycobiology/Glycomics Market 2014-2019: Enzymes, Instruments, Kits, and Reagents
M2 - Mon Dec 08, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sj4p7d/glycobiologyglyco) has announced the addition of the "Glycobiology/Glycomics Market by Product, Application & by End User - Global Forecast to 2019" report to their offering. The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market. This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Glycomics Market, By Product 8 Glycomics Market, By Application 9 Glycomics Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bruker Corporation - Danaher Corporation - New England Biolabs - Prozyme - Shimadzu Corporation - Sigma-Aldrich Corporation - Takara Bio - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/sj...ologyglyco
A: 41.13 (-0.24), SIAL: 137.16 (-0.01), DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Metabolomics: Technologies and Applications - A Global Market Overview
M2 - Fri Nov 28, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/rkdkz4/metabolomics) has announced the addition of the "Metabolomics: Technologies and Applications - A Global Market Overview" report to their offering. The global markets for the above mentioned metabolomic analytical techniques, end-use applications and the therapeutic areas are analyzed in terms of value in USD. Metabolomic separation techniques account for over half of the global metabolomics market estimated at US$395.2 million in 2014 while detection techniques shares with US$308.8 million. Biomarker discovery projected to be the fastest growing end use sector with 2014-2020 CAGR of 25.2% and also estimated the largest market for metabolomics in 2014 with US$252.8 million closely followed by drug discovery with US$211.1 million. The report reviews, analyses and projects the metabolomics technologies, applications and therapeutic areas market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 9 independent countries across North America - The United States and Canada; Europe - France, Germany, Italy and the United Kingdom; Asia-Pacific - China, India and Japan. This global market report includes 306 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 20 key global players and 33 major players across North America - 20; Europe - 9; and Asia-Pacific - 4. The research also provides the listing of the companies engaged in research and development, manufacturing and supply of metabolomics technologies and instruments. The global list of companies covers addresses, contact numbers and the website addresses of 92 companies. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. APPLICATION ANALYSIS OF METABOLOMICS 3. KEY MARKET TRENDS 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC PART
ANNEXURE Companies Mentioned - Agilent Technologies - BASF SE - Biocrates Life Sciences AG - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - Genedata AG - GERSTEL GmbH & Co. KG - Human Metabolome Technologies, Inc. - LECO Corporation - Metabolomic Discoveries GmbH - Metabolomic Technologies Inc. - Metabolomx - Metabolon, Inc. - Phenomenome Discoveries Inc. - Shimadzu Corporation - Sigma-Aldrich Co. LLC. - Stemina Biomarker Discovery, Inc. - Thermo Fisher Scientific Inc - Waters Corporation For more information visit http://www.researchandmarkets.com/research/rk...tabolomics A: 41.13 (-0.24), DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters
PR Newswire - Wed Nov 26, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Sequenom Inc. (NASDAQ: SQNM), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), Affymetrix Inc. (NASDAQ: AFFX), and Waters Corporation (NYSE: WAT). Free research on these five companies can be accessed at:http://investor-edge.com/register. The US markets on Tuesday, November 25, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,814.94, down 0.02% and the NASDAQ Composite closed at 4,758.25, up 0.07%. The S&P 500 finished the session 0.12% lower at 2,067.03. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 793.40, up 0.07%, with the index advancing 8.30% in the previous three months. Register for your complimentary reports on these five stocks at:
SQNM: 3.59 (-0.01), ILMN: 186.22 (+2.72), PKI: 43.99 (-0.06), WAT: 114.54 (+0.21), AFFX: 9.80 (+0.05)
Metabolomics Market - By Indication (Oncology, Cardiology) worth $2,100 Million by 2019 - Prominent Players in this Market - Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.) & Waters Corporation (U.S.)
M2 - Mon Nov 24, 3:44AM CST
According to a new market research report The "Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
DHR: 86.79 (-0.27), WAT: 114.54 (+0.21)
Waters Corporation to Gain from Strength in Pharmaceuticals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:40PM CST
On Nov 20, 2014, we issued an updated research report on Waters Corporation (WAT).
BLT: 17.52 (+0.17), WAT: 114.54 (+0.21)
12.1% Return Seen to Date on SmarTrend Waters Call (WAT)
Comtex SmarTrend(R) - Fri Nov 21, 9:38AM CST
SmarTrend identified an Uptrend for Waters (NYSE:WAT) on October 21st, 2014 at $103.89. In approximately 1 month, Waters has returned 12.06% as of today's recent price of $116.42.
WAT: 114.54 (+0.21)
Watch for Waters to Potentially Pullback After Gaining 1.38% Yesterday
Comtex SmarTrend(R) - Thu Nov 20, 4:27PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $114.13 to a high of $116.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $114.58 on volume of 962,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 114.54 (+0.21)
Waters Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Nov 20, 4:27PM CST
Waters (NYSE:WAT) traded in a range yesterday that spanned from a low of $114.13 to a high of $116.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $114.58 on volume of 962,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WAT: 114.54 (+0.21)
Global Chiral Chromatography Column Market Outlook, 2018 - Key Analysis of the $87 Million Industry
M2 - Tue Nov 18, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vtffgd/chiral) has announced the addition of the "Chiral Chromatography Column Market by type, Material, & by Application - Forecast to 2018" report to their offering. The chiral chromatography columns market size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2% Chiral Chromatography has evolved over the years and has become a method of choice for analysis, identification, and purification of a wide variety of compounds. The market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures in lesser amounts of time and provide more detailed results. This report categorizes the market into two broad segments, based upon type of columns, into empty columns and pre-packed columns. Thepre-packed columns market comprises of analytical and preparative columns. The analytical columns accounts for 62% of the overall market. The chiral chromatography columns market, by applications, is segmented into Liquid Chromatography (LC), Gas Chromatography (GC), Thin-layer chromatography (TLC),and Supercritical Fluid Chromatography (SFC). The LC market is further classified into High Performance Liquid Chromatography (HPLC), Ultra-High Performance Liquid Chromatography (UHPLC), Ultra-Fast Liquid Chromatography (UFLC) and Flash Chromatography. The Liquid chromatography (LC) subsegment holds the largest share 69% of the overall market in 2013. This high share of LC systems is attributed to the large-scale application of HPLC systems and the rising use of UHPLC systems. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Chiral Chromatography Columns Market, By Type 7 Chiral Chromatography Market, By Material 8 Chiral Chromatography Market, By Application 9 Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies - Daicel Corporation - Phenomenex, Inc. - Shimadzu Corporation - Sigma Aldrich Corporation - Thermo Fisher Scientific, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/vtffgd/chiral
A: 41.13 (-0.24), WAT: 114.54 (+0.21)
Waters Corporation Presentation at the Stifel 2014 Healthcare Conference to Be Webcast Live
Business Wire - Tue Nov 11, 12:10PM CST
Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will speak to the investment community at the Stifel 2014 Healthcare Conference at the New York Palace Hotel in New York, on Tuesday, November 18, 2014, at 8:00 a.m. Eastern Time.
WAT: 114.54 (+0.21)
Waters PATROL UPLC Process Analysis System Receives Product Innovation Leadership Award from Frost & Sullivan
Business Wire - Tue Nov 11, 8:05AM CST
Waters Corporation (WAT:NYSE) today announced it received the 2014 Product Innovation Award for PATROL UPLC(R) Process Analysis System from Frost & Sullivan in the Global Process Liquid Chromatography market.
WAT: 114.54 (+0.21)
Waters Earnings Review: 20 Days after Announcement Shares Up 3.6% (WAT)
Comtex SmarTrend(R) - Mon Nov 10, 10:53AM CST
When Waters (NYSE:WAT) reported earnings two weeks ago on October 21st, 2014, analysts, on average, expected the company to report earnings of $1.28 on sales of $486.7 million. The company actually reported EPS of $1.38 on sales of $493.2 million, beating EPS estimates by $0.09 and beating revenue estimates by $6.5 million. Shares of Waters have climbed from $107.17 to $111.05, representing a gain of 3.6% since the company reported earnings 20 days ago.
WAT: 114.54 (+0.21)
Waters Centers of Innovation Program Honors Colorado State University Laboratory
Business Wire - Tue Oct 28, 9:18AM CDT
At a ceremony at Colorado State University's Fort Collins, CO campus, Waters Corporation officially welcomed the University's Proteomics and Metabolomics Facility into its Centers of Innovation Program. Under the direction of Dr. Jessica Prenni, the facility has earned a reputation for excellence in applying non-targeted proteomics and metabolomics using liquid chromatography and mass spectrometry (LC/MS) to advance food and veterinary science and clinical and microbacterial research.
WAT: 114.54 (+0.21)
Position Paper Release, Acquisition Agreement, Quarterly Earnings, Technical Updates, and New Medicare Plans - Research Reports on Intercontinental, Marsh & McLennan, Waters, Teva and WellPoint
PR Newswire - Mon Oct 27, 7:50AM CDT
Today, Analysts Review released its research reports regarding Intercontinental Exchange, Inc. (NYSE: ICE), Marsh & McLennan Companies, Inc. (NYSE: MMC), Waters Corporation (NYSE: WAT), Teva Pharmaceutical Industries Limited (NYSE: TEVA) and WellPoint Inc. (NYSE: WLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7440-100free.
ICE: 221.73 (-1.70), TEVA: 57.09 (+0.33), WLP: 128.71 (+0.94), WAT: 114.54 (+0.21), MMC: 58.32 (-0.07)
Waters (WAT) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 22, 11:08AM CDT
The following Waters (WAT) conference call took place on October 21, 2014, 08:30 AM ET. This is a transcript of that earnings call:
WAT: 114.54 (+0.21)
Waters Corporation Selects Lecorpio's IP Management Solution to Unify Patent Process and Drive Better Business Decisions
PR Newswire - Wed Oct 22, 10:03AM CDT
Lecorpio, the leader in cloud-based Intellectual Property (IP) management and analytics, today announced that Waters Corporation has selected Lecorpio's intellectual asset management solution to unify its IP program and provide analytics to drive better business decisions.
WAT: 114.54 (+0.21)
NYSE stocks posting largest percentage increases
AP - Tue Oct 21, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
HLF: 37.98 (+0.20), POST: 42.51 (+0.49), W: 20.44 (-0.35), LRE: 7.00 (-0.20), LII: 95.68 (-0.36), ESI: 10.18 (-0.01), TRN: 28.45 (+0.07), PER: 6.38 (-0.16), VSLR: 8.97 (+0.18), WAT: 114.54 (+0.21), CNL: 55.15 (+0.20), SB: 3.86 (-0.17), PKG: 78.90 (-0.11)
Why Waters (WAT) Stock Is Up Today
at The Street - Tue Oct 21, 11:45AM CDT
Waters (WAT) is gaining Tuesday after beating analysts' estimates for earnings and revenue in the third quarter.
WAT: 114.54 (+0.21)
Waters (WAT) Marked As A Barbarian At The Gate
at The Street - Tue Oct 21, 11:41AM CDT
Trade-Ideas LLC identified Waters (WAT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
WAT: 114.54 (+0.21)
